» Articles » PMID: 1939566

Heterogeneity, Persistence, and Distribution of Pseudomonas Aeruginosa Genotypes in Cystic Fibrosis Patients

Overview
Specialty Microbiology
Date 1991 Oct 1
PMID 1939566
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A collection of 222 isolates of Pseudomonas aeruginosa was obtained from the respiratory tract of 16 patients with cystic fibrosis over a 4- to 9-month period. Fourteen of these patients were unrelated, while the remaining two were siblings. Isolates were typed by conventional pyocin typing and also by the use of a DNA probe containing 741 bp immediately upstream of the exotoxin A structural gene and the initial 732 bp of the exotoxin A structural gene. By pyocin typing, 69% (11 of 16) of the patients were shown to harbor a single type that persisted in the lung throughout the study. By genotyping (DNA probe typing), all but three patients (13 of 16, 81%) harbored a single persistent genotype in their lungs. Six patients other than the sibling pair (6 of 14, 43%) shared a common genotype in their lungs as judged by DNA probing, and the pyocin type of these isolates was also identical. In four of these six patients, the shared genotype was also the persistent genotype. The sibling pair studied also carried a common genotype in their lungs as indicated by DNA probing, even though the pyocin type of these isolates varied. Results presented suggest that the majority of patients harbor a persistent strain in their lungs and that cross-colonization may occur.

Citing Articles

Bacteriocin-mediated competition in cystic fibrosis lung infections.

Ghoul M, West S, Krogh Johansen H, Molin S, Harrison O, Maiden M Proc Biol Sci. 2015; 282(1814).

PMID: 26311664 PMC: 4571691. DOI: 10.1098/rspb.2015.0972.


The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.

Delhaes L, Monchy S, Frealle E, Hubans C, Salleron J, Leroy S PLoS One. 2012; 7(4):e36313.

PMID: 22558432 PMC: 3338676. DOI: 10.1371/journal.pone.0036313.


Comparing the microbiota of the cystic fibrosis lung and human gut.

Rogers G, Carroll M, Hoffman L, Walker A, Fine D, Bruce K Gut Microbes. 2011; 1(2):85-93.

PMID: 21326915 PMC: 3023585. DOI: 10.4161/gmic.1.2.11350.


Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples.

Waine D, Honeybourne D, Smith E, Whitehouse J, Dowson C J Clin Microbiol. 2009; 47(11):3444-8.

PMID: 19710263 PMC: 2772629. DOI: 10.1128/JCM.00459-09.


Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Mahenthiralingam E, CAMPBELL M, Foster J, Lam J, Speert D J Clin Microbiol. 1996; 34(5):1129-35.

PMID: 8727889 PMC: 228968. DOI: 10.1128/jcm.34.5.1129-1135.1996.


References
1.
Pedersen S, Koch C, Hoiby N, ROSENDAL K . An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 1986; 17(4):505-16. DOI: 10.1093/jac/17.4.505. View

2.
Ojeniyi B, Baek L, Hoiby N . Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Acta Pathol Microbiol Immunol Scand B. 1985; 93(1):7-13. DOI: 10.1111/j.1699-0463.1985.tb02844.x. View

3.
Ogle J, Janda J, Woods D, Vasil M . Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis. 1987; 155(1):119-26. DOI: 10.1093/infdis/155.1.119. View

4.
Speert D, CAMPBELL M . Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect. 1987; 9(1):11-21. DOI: 10.1016/0195-6701(87)90089-2. View

5.
Thomassen M, Demko C, DOERSHUK C . Cystic fibrosis: a review of pulmonary infections and interventions. Pediatr Pulmonol. 1987; 3(5):334-51. DOI: 10.1002/ppul.1950030510. View